The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting highly aggressive ductal prostate tumours with poly ADP ribose polymerase inhibitor (PARPi) and androgen receptor signaling inhibitor (ARSi) combination therapy.
 
Weranja Ranasinghe
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - pacific edge
 
Mahsa Delavar
No Relationships to Disclose
 
Mitchell Lawrence
Research Funding - AstraZeneca
Other Relationship - Pfizer
 
Nicholas Choo
No Relationships to Disclose
 
Birunthi Niranjan
No Relationships to Disclose
 
Melissa Papagiris
No Relationships to Disclose
 
Jenna Kraska
No Relationships to Disclose
 
Hong Wang
No Relationships to Disclose
 
Shivakumar Keerthikumar
No Relationships to Disclose
 
Ganiraju Manyam
No Relationships to Disclose
 
Patricia Troncoso
No Relationships to Disclose
 
Peter Shephard
No Relationships to Disclose
 
Timothy Thompson
Research Funding - Bayer-MDACC Alliance Research Project (indirect funding)
Patents, Royalties, Other Intellectual Property - Baylor College of Medicine
 
Renea Taylor
Research Funding - AstraZeneca
 
Brian Chapin
Consulting or Advisory Role - Blue Earth Diagnostics; Johnson & Johnson
Research Funding - Blue Earth Diagnostics
(OPTIONAL) Uncompensated Relationships - Janssen; Merck; Pfizer; Regeneron
 
Gail Risbridger
Consulting or Advisory Role - AstraZeneca/UK
Research Funding - AstraZeneca/UK